Lawmakers Fight FDA's Anti-Estriol Stance

Law360, New York (May 8, 2008, 12:00 AM EDT) -- In the wake of the U.S. Food and Drug Administration's backlash against bioidentical hormone replacement drugs, lawmakers introduced a resolution Tuesday opposing the agency's policy restricting women's access to the products.

The bipartisan motion, introduced in the U.S. House of Representatives by Rep. Mike Ross (D-Ark.), is intended to express the sense of Congress that the FDA's new policy restricting women's access to medications containing estriol – a weaker form of the hormone estrogen – “does not serve the public interest” and urging the agency to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.